Viva Biotech's antibody production platform efficiently expresses antibody proteins, leveraging both transient transfection and stable cell line methodologies. The platform boasts impressive IgG1 yields, achieving up to 5-10 g/L. It's capable of producing a diverse array of antibody forms, including IgG, IgM, IgA, bispecific antibodies, Fab fragments, scFv, and VHH. In addition to protein expression, Viva Biotech offers specialized chemical fluorescence labeling services. Utilizing both amino and NHS coupling techniques, these services precisely attach fluorescent dye molecules, with a strict quality control process ensuring the integrity of the labeled products. Post-production, the antibody proteins undergo a series of stability and drug-related studies, as well as characterization analyses. These processes are vital to confirm that the antibodies retain their functional efficacy under various conditions, aligning with the rigorous demands of scientific research and the pharmaceutical industry.
Case Study: Bispecific Ab
Case Study: Fab/IgG
CHO Cell Expression System
lgG、lgM、lgA、Bispectific、Fab、 scFv and VHH
Chemical fluorescent labeling of antibodies
Amino coupling, NHS coupling
Quality inspection of labeled products
Structural modification of fluorescent dye molecules
Accelerated Stability Analysis (The activity of antibodies before and post treatment)
“Antibody Production and Identification Platform”, please contact our team.